ECONOMIC IMPACT OF NON-RESPONSE TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS PATIENTS

被引：0
|
作者：
Sharma, Parivrudh [1 ]
Crighton, Lynne [2 ]
Vijayan, Balasubramaniam [3 ]
English, Shirley [3 ]
Mukhopadhya, Ashis [3 ]
机构：
[1] Univ Aberdeen, Aberdeen, Scotland
[2] Aberdeen Royal Infirm, Pharm Dept, Aberdeen, Scotland
[3] Aberdeen Royal Infirm, Dept Digest Disorders, Aberdeen, Scotland
来源：
GUT | 2019年 / 68卷
关键词：
D O I：
10.1136/gutjnl-2019-BSGAbstracts.244
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PTU-035
引用
收藏
页码：A129 / A130
页数：2
相关论文
共 50 条
  • [31] Determinants of the effectiveness of bezafibrate combined with ursodeoxycholic acid in patients with primary biliary cholangitis
    Matsumoto, Kosuke
    Hirohara, Junko
    Takeuchi, Akihito
    Miura, Ryo
    Asaoka, Yoshinari
    Nakano, Toshiaki
    Tanaka, Atsushi
    HEPATOLOGY RESEARCH, 2023, 53 (10) : 989 - 997
  • [32] EFFECT OF FIBRATE-ADD-ON TREATMENT IN PRIMARY BILIARY CHOLANGITIS PATIENTS WITH AN INSUFFICIENT RESPONSE TO URSODEOXYCHOLIC ACID
    Freissmuth, C.
    Kozbial, K.
    Staettermayer, A. F.
    Beinhardt, S.
    Stern, R.
    Halilbasic, E.
    Ferenci, P.
    Trauner, M.
    Hofer, H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S434 - S435
  • [33] EVALUATION OF PROGNOSTIC MODELS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS RECEIVING URSODEOXYCHOLIC ACID
    Alomari, Mohammad
    Covut, Fahrettin
    Chadalavada, Pravallika
    Gunasekaran, Deepthi
    Padbidri, Vinay S.
    Al Momani, Laith
    Khazaaleh, Shrouq
    Romero-Marrero, Carlos
    GASTROENTEROLOGY, 2019, 156 (06) : S1321 - S1321
  • [34] Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis
    John, Binu V.
    Khakoo, Nidah S.
    Schwartz, Kaley B.
    Aitchenson, Gabriella
    Levy, Cynthia
    Dahman, Bassam
    Deng, Yangyang
    Goldberg, David S.
    Martin, Paul
    Kaplan, David E.
    Taddei, Tamar H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (09): : 1913 - 1923
  • [35] Incomplete response to ursodeoxycholic acid in primary biliary cholangitis: criteria, epidemiology, and possible mechanisms
    Huang, Lin-Xiang
    Wang, Zi-Long
    Jin, Rui
    Chen, Hong-Song
    Feng, Bo
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (11-12) : 1065 - 1078
  • [36] IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate
    Takano, Keiko
    Saeki, Chisato
    Oikawa, Tsunekazu
    Hidaka, Akihisa
    Mizuno, Yusuke
    Ishida, Jinya
    Takakura, Kazuki
    Nakano, Masanori
    Torisu, Yuichi
    Amano, Katsushi
    Ishikawa, Tomohisa
    Zeniya, Mikio
    Tsubota, Akihito
    Saruta, Masayuki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (04) : 663 - 672
  • [37] Ciprofibrate: a new option of fibrate for primary biliary cholangitis with incomplete response to ursodeoxycholic acid
    Guedes, Laura
    Braga, Michele Harriz
    Moutinho, Bruna Damasio
    Carrilho, Flair Jose
    Rachid Cancado, Eduardo Luiz
    JOURNAL OF HEPATOLOGY, 2020, 73 : S479 - S479
  • [38] Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response
    Reig, Anna
    Sese, Pilar
    Pares, Albert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (01): : 49 - 55
  • [39] In primary biliary cholangitis, adding bezafibrate to ursodeoxycholic acid increased complete biochemical response
    Korula, Jacob
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (08) : JC45 - JC45
  • [40] Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review
    Suraweera, Duminda
    Rahal, Harman
    Jimenez, Melissa
    Viramontes, Matthew
    Choi, Gina
    Saab, Sammy
    LIVER INTERNATIONAL, 2017, 37 (12) : 1877 - 1886
12345